Activation of vasculogenic progenitor cells by ent-16α,17-dihydroxy- kauran-19-oic acid

So Hyun Park, Yun Mi Jeong, Ji Hye Kim, Hyung Min Chung, Wonhee Suh, Sang Hyun Sung, Sang Gyu Park, Jong Hyuk Sung

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Vasculogenic progenitor cells (VPCs) circulate in the blood and have the ability to differentiate into endothelial cells that make up the lining of blood vessels. Therefore, VPC transplantation is a new strategy for the treatment of ischemic diseases. Because priming/preconditioning of VPCs before transplantation enhances their regenerative potential, the present study investigated whether ent-16α,17-dihydroxy-kauran-19-oic acid (DHK) isolated from Siegesbeckia pubescens could stimulate/activate VPCs in vitro. Therefore, the effect of DHK (1-100 μM concentration) on the proliferation, migration, and tube forming of VPCs was examined in various systems, and related signaling pathways were identified. DHK treatment significantly increased the proliferation, migration, and tube formation of VPCs in a dose-dependent manner. Phosphorylation of extracellular signal-regulated kinase (ERK)1/2 and Akt was significantly increased by DHK, but chemical inhibitors against ERK1/2 (U0126) and Akt (LY294002) significantly attenuated DHK-enhanced proliferation, migration, and tube formation of VPCs. Collectively, these results indicated that DHK shows promise as a novel VPC primer/activator.

Original languageEnglish
Pages (from-to)1801-1807
Number of pages7
JournalBiological and Pharmaceutical Bulletin
Volume34
Issue number12
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Stem Cells
Acids
Cell Transplantation
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Blood Vessels
Endothelial Cells
Phosphorylation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Park, So Hyun ; Jeong, Yun Mi ; Kim, Ji Hye ; Chung, Hyung Min ; Suh, Wonhee ; Sung, Sang Hyun ; Park, Sang Gyu ; Sung, Jong Hyuk. / Activation of vasculogenic progenitor cells by ent-16α,17-dihydroxy- kauran-19-oic acid. In: Biological and Pharmaceutical Bulletin. 2011 ; Vol. 34, No. 12. pp. 1801-1807.
@article{b37a6e56860a4afbbdcfecbf9eb17de8,
title = "Activation of vasculogenic progenitor cells by ent-16α,17-dihydroxy- kauran-19-oic acid",
abstract = "Vasculogenic progenitor cells (VPCs) circulate in the blood and have the ability to differentiate into endothelial cells that make up the lining of blood vessels. Therefore, VPC transplantation is a new strategy for the treatment of ischemic diseases. Because priming/preconditioning of VPCs before transplantation enhances their regenerative potential, the present study investigated whether ent-16α,17-dihydroxy-kauran-19-oic acid (DHK) isolated from Siegesbeckia pubescens could stimulate/activate VPCs in vitro. Therefore, the effect of DHK (1-100 μM concentration) on the proliferation, migration, and tube forming of VPCs was examined in various systems, and related signaling pathways were identified. DHK treatment significantly increased the proliferation, migration, and tube formation of VPCs in a dose-dependent manner. Phosphorylation of extracellular signal-regulated kinase (ERK)1/2 and Akt was significantly increased by DHK, but chemical inhibitors against ERK1/2 (U0126) and Akt (LY294002) significantly attenuated DHK-enhanced proliferation, migration, and tube formation of VPCs. Collectively, these results indicated that DHK shows promise as a novel VPC primer/activator.",
author = "Park, {So Hyun} and Jeong, {Yun Mi} and Kim, {Ji Hye} and Chung, {Hyung Min} and Wonhee Suh and Sung, {Sang Hyun} and Park, {Sang Gyu} and Sung, {Jong Hyuk}",
year = "2011",
month = "1",
day = "1",
doi = "10.1248/bpb.34.1801",
language = "English",
volume = "34",
pages = "1801--1807",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "12",

}

Activation of vasculogenic progenitor cells by ent-16α,17-dihydroxy- kauran-19-oic acid. / Park, So Hyun; Jeong, Yun Mi; Kim, Ji Hye; Chung, Hyung Min; Suh, Wonhee; Sung, Sang Hyun; Park, Sang Gyu; Sung, Jong Hyuk.

In: Biological and Pharmaceutical Bulletin, Vol. 34, No. 12, 01.01.2011, p. 1801-1807.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Activation of vasculogenic progenitor cells by ent-16α,17-dihydroxy- kauran-19-oic acid

AU - Park, So Hyun

AU - Jeong, Yun Mi

AU - Kim, Ji Hye

AU - Chung, Hyung Min

AU - Suh, Wonhee

AU - Sung, Sang Hyun

AU - Park, Sang Gyu

AU - Sung, Jong Hyuk

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Vasculogenic progenitor cells (VPCs) circulate in the blood and have the ability to differentiate into endothelial cells that make up the lining of blood vessels. Therefore, VPC transplantation is a new strategy for the treatment of ischemic diseases. Because priming/preconditioning of VPCs before transplantation enhances their regenerative potential, the present study investigated whether ent-16α,17-dihydroxy-kauran-19-oic acid (DHK) isolated from Siegesbeckia pubescens could stimulate/activate VPCs in vitro. Therefore, the effect of DHK (1-100 μM concentration) on the proliferation, migration, and tube forming of VPCs was examined in various systems, and related signaling pathways were identified. DHK treatment significantly increased the proliferation, migration, and tube formation of VPCs in a dose-dependent manner. Phosphorylation of extracellular signal-regulated kinase (ERK)1/2 and Akt was significantly increased by DHK, but chemical inhibitors against ERK1/2 (U0126) and Akt (LY294002) significantly attenuated DHK-enhanced proliferation, migration, and tube formation of VPCs. Collectively, these results indicated that DHK shows promise as a novel VPC primer/activator.

AB - Vasculogenic progenitor cells (VPCs) circulate in the blood and have the ability to differentiate into endothelial cells that make up the lining of blood vessels. Therefore, VPC transplantation is a new strategy for the treatment of ischemic diseases. Because priming/preconditioning of VPCs before transplantation enhances their regenerative potential, the present study investigated whether ent-16α,17-dihydroxy-kauran-19-oic acid (DHK) isolated from Siegesbeckia pubescens could stimulate/activate VPCs in vitro. Therefore, the effect of DHK (1-100 μM concentration) on the proliferation, migration, and tube forming of VPCs was examined in various systems, and related signaling pathways were identified. DHK treatment significantly increased the proliferation, migration, and tube formation of VPCs in a dose-dependent manner. Phosphorylation of extracellular signal-regulated kinase (ERK)1/2 and Akt was significantly increased by DHK, but chemical inhibitors against ERK1/2 (U0126) and Akt (LY294002) significantly attenuated DHK-enhanced proliferation, migration, and tube formation of VPCs. Collectively, these results indicated that DHK shows promise as a novel VPC primer/activator.

UR - http://www.scopus.com/inward/record.url?scp=83255164200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83255164200&partnerID=8YFLogxK

U2 - 10.1248/bpb.34.1801

DO - 10.1248/bpb.34.1801

M3 - Article

VL - 34

SP - 1801

EP - 1807

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 12

ER -